Page last updated: 2024-08-26

fotemustine and Astrocytoma, Grade IV

fotemustine has been researched along with Astrocytoma, Grade IV in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (6.67)18.2507
2000's13 (43.33)29.6817
2010's14 (46.67)24.3611
2020's1 (3.33)2.80

Authors

AuthorsStudies
Beige, A; Borsotti, F; Farah, W; Ghiringhelli, F; Ilie, SM; Lecuelle, J; Mazilu, I; Truc, G; Truntzer, C; Vincent, J1
Baldaccini, D; Bazzoli, E; Bocci, G; Cantarella, M; Catania, F; Delishaj, D; Fabi, A; Fabrini, MG; Franchino, F; Gonnelli, A; Lolli, I; Lombardi, G; Molinari, A; Montrone, S; Morganti, R; Pace, A; Paiar, F; Pasqualetti, F; Pellerino, A; Rudà, R; Soffietti, R; Villani, V; Vivaldi, C; Zagonel, V1
Buonerba, C; Cerbone, L; Cordua, N; De Placido, S; Di Lorenzo, G; Lamberti, G; Marinelli, A; Peluso, G1
Berardi, R; Burattini, L; Cascinu, S; Detti, B; Fabrini, MG; Iacovelli, R; Lolli, I; Perrone, F; Santoni, M; Savio, G; Scoccianti, S; Silvano, G1
Bulzonetti, N; D'Elia, A; De Felice, F; Musio, D; Salvati, M; Tombolini, V1
Bertero, L; Cassoni, P; Castiglione, A; Ciccone, G; Fabrini, MG; Lolli, I; Morra, I; Pasqualetti, F; Rudà, R; Soffietti, R; Trevisan, E1
Della Puppa, A; Farina, P; Fiduccia, P; Lombardi, G; Pambuku, A; Roma, A; Zagonel, V; Zustovich, F1
Artuso, S; Balestrieri, ML; Caraglia, M; De Rosa, G; Leonetti, C; Luce, A; Lusa, S; Porru, M; Salzano, G; Stoppacciaro, A; Zappavigna, S1
Lai, T; Lian, L; Liu, D; Liu, J; Liu, Z; Wang, J; Zhang, G; Zhu, L; Zhuang, X1
Agati, R; Brandes, AA; Caserta, C; Clavarezza, M; Eoli, M; Eusebi, V; Fabi, A; Finocchiaro, G; Franceschi, E; Lombardi, G; Maiello, E; Monteforte, M; Proietti, E; Reni, M; Zagonel, V1
Ammannati, F; Biti, G; Bordi, L; Borghesi, S; Detti, B; Iannalfi, A; Leonulli, BG; Martinelli, F; Meattini, I; Sardaro, A; Scoccianti, S1
Cionini, L; Fabrini, MG; Lolli, I; Marsella, A; Perrone, F; Scotti, V; Silvano, G1
Amistà, P; Bianchini, C; Blatt, V; Brandes, AA; Ermani, M; Faedi, M; Franceschi, E; Gardiman, M; Labianca, R; Reni, M; Santoro, A; Tosoni, A1
Addeo, R; Caraglia, M; De Santi, MS; Del Prete, S1
Buonerba, C; De Placido, S; Di Lorenzo, G; Gallo, C; Marinelli, A; Romeo, V1
Abbruzzese, A; Addeo, R; Caraglia, M; Carraturo, M; Cennamo, G; De Santi, MS; Del Prete, S; Faiola, V; Genovese, M; Montella, L; Parlato, C; Vincenzi, B1
Botturi, A; Ferrari, D; Gaviani, P; Lamperti, E; Salmaggi, A; Silvani, A; Simonetti, G1
Albanese, A; Anile, C; Balducci, M; Chiesa, S; D'Agostino, GR; De Bari, B; De Rose, F; Diletto, B; Fiorentino, A; Frascino, V; Manfrida, S; Mangiola, A; Mantini, G; Micciche', F; Morganti, AG; Valentini, V1
Burattini, L; Cascinu, S; Onofri, A; Paccapelo, A; Santoni, M1
Dieckmann, K; Fazeny-Dörner, B; Hainfellner, J; Marosi, C; Piribauer, M; Rössler, K; Ungersböck, K; Veitl, M; Wenzel, C1
Dieckmann, K; Fazeny-Dörner, B; Marosi, C; Piribauer, M; Rössler, K; Ungersböck, K; Veitl, M; Wenzel, C1
Baumgartner, G; Budinsky, A; Czech, T; Dieckmann, K; Fazeny-Dörner, B; Gyries, A; Killer, M; Marosi, C; Muhm, M; Piribauer, M; Prayer, D; Rössler, K; Ungersböck, K; Veitl, M1
Fazeny-Dörner, B; Mader, RM; Marosi, C; Piribauer, M; Rizovski, B; Stögermaier, B1
Audra, P; Cartalat-Carel, S; Colin, P; Ducray, F; Gaucherand, P; Honnorat, J; Mahla, K; Pelissou-Guyotat, I; Trouillas, P1
Boiardi, A; Botturi, A; Eoli, M; Falcone, C; Filippini, G; Fiumani, A; Gaviani, P; Lamperti, E; Salmaggi, A; Silvani, A1
Kobiakov, GL1
Dam-Hieu, P; Labat, JP; Lucas, B; Malhaire, JP; Person, H; Simon, H1
Bryce, R; Etienne, MC; Ferrero, JM; Fischel, JL; Formento, P; Ilc, K; Milano, G1
Bondiau, PY; Chatel, M; Frenay, M; Lebrun, C; Lonjon, M1
Cagli, S; Dalbasti, T; Oktar, N; Ozdamar, N1

Reviews

1 review(s) available for fotemustine and Astrocytoma, Grade IV

ArticleYear
[Clinical significance of mustoforan in management of malignant glioma].
    Voprosy onkologii, 2007, Volume: 53, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Nitrosourea Compounds; Oligodendroglioma; Organophosphorus Compounds; Semustine; Survival Analysis; Treatment Outcome

2007

Trials

12 trial(s) available for fotemustine and Astrocytoma, Grade IV

ArticleYear
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients: A phase I/II trial.
    Medicine, 2018, Volume: 97, Issue:27

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Glioblastoma; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Temozolomide; Thrombocytopenia

2018
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology).
    Journal of neuro-oncology, 2014, Volume: 116, Issue:3

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Italy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neurologic Examination; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Survival Analysis; Time Factors; Tumor Suppressor Proteins

2014
AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma.
    Neuro-oncology, 2016, Volume: 18, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Survival Rate

2016
Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience.
    Anti-cancer drugs, 2008, Volume: 19, Issue:6

    Topics: Adult; Aged; Brain Neoplasms; Dacarbazine; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Prospective Studies; Temozolomide

2008
A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma.
    Journal of neuro-oncology, 2009, Volume: 92, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds

2009
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence; Temozolomide

2009
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.
    Journal of neuro-oncology, 2011, Volume: 102, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Confidence Intervals; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Odds Ratio; Organophosphorus Compounds; Temozolomide; Time Factors; Tomography, X-Ray Computed

2011
Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.
    British journal of cancer, 2003, Feb-24, Volume: 88, Issue:4

    Topics: Adolescent; Adult; Aged; Dacarbazine; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Survival Analysis; Survival Rate

2003
Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme.
    Anti-cancer drugs, 2003, Volume: 14, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Salvage Therapy; Survival Rate

2003
Preliminary study on pharmacokinetics of dacarbazine and fotemustine in glioblastoma multiforme patients does not indicate gender-specific differences.
    Anti-cancer drugs, 2004, Volume: 15, Issue:5

    Topics: Adult; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Dacarbazine; Dose-Response Relationship, Drug; Female; Glioblastoma; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Sex Factors

2004
Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.
    Journal of neuro-oncology, 2008, Volume: 87, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Procarbazine; Salvage Therapy; Temozolomide

2008
Local interstitial chemotherapy with sustained release bucladesine in de novo glioblastoma multiforme: a preliminary study.
    Journal of neuro-oncology, 2002, Volume: 56, Issue:2

    Topics: Adult; Antineoplastic Agents; Bone Marrow; Bucladesine; Delayed-Action Preparations; Drug Implants; Drug Therapy, Combination; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Randomized Controlled Trials as Topic; Surgical Wound Infection; Survival Rate

2002

Other Studies

17 other study(ies) available for fotemustine and Astrocytoma, Grade IV

ArticleYear
Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study.
    Anticancer research, 2022, Volume: 42, Issue:12

    Topics: Bevacizumab; Chronic Disease; Cytotoxins; Glioblastoma; Humans; Irinotecan; Recurrence; Retrospective Studies; Temozolomide

2022
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.
    American journal of clinical oncology, 2018, Volume: 41, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Immunological; Bevacizumab; Brain Neoplasms; Female; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Young Adult

2018
Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma.
    Journal of neuro-oncology, 2013, Volume: 113, Issue:3

    Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Glioblastoma; Humans; Male; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate

2013
Low-dose fotemustine as second-line chemotherapy for recurrent glioblastoma multiforme.
    Anticancer research, 2013, Volume: 33, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence

2013
The combination of carmustine wafers and fotemustine in recurrent glioblastoma patients: a monoinstitutional experience.
    BioMed research international, 2014, Volume: 2014

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds

2014
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.
    Oncotarget, 2014, Nov-15, Volume: 5, Issue:21

    Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dacarbazine; Diphosphonates; Drug Delivery Systems; Drug Resistance, Neoplasm; Glioblastoma; Humans; Imidazoles; Male; Mice; Mice, Inbred Strains; Nanoparticles; Nitrosourea Compounds; Organophosphorus Compounds; Temozolomide; Transferrin; Tumor Burden; Xenograft Model Antitumor Assays; Zoledronic Acid

2014
Retrospective analysis of bevacizumab in combination with fotemustine in chinese patients with recurrent glioblastoma multiforme.
    BioMed research international, 2015, Volume: 2015

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bevacizumab; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Retrospective Studies; Young Adult

2015
Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Glioblastoma; Humans; Methylation; Neoplasm Recurrence, Local; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Promoter Regions, Genetic; Randomized Controlled Trials as Topic

2009
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme?
    Journal of neuro-oncology, 2010, Volume: 100, Issue:2

    Topics: Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; DNA Modification Methylases; DNA Repair Enzymes; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Radiotherapy, Conformal; Tumor Suppressor Proteins

2010
Lecture: fotemustine in brain tumors.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2011, Volume: 32 Suppl 2

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Glioblastoma; Humans; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds

2011
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study.
    Neuro-oncology, 2012, Volume: 14, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Dacarbazine; Dose Fractionation, Radiation; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Temozolomide

2012
Twice-daily dosing of temozolomide in combination with fotemustine for the treatment of patients with refractory glioblastoma.
    Anticancer research, 2012, Volume: 32, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Drug Administration Schedule; Female; Glioblastoma; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Temozolomide

2012
Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center.
    Wiener klinische Wochenschrift, 2003, Jun-24, Volume: 115, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Trials as Topic; Cobalt Radioisotopes; Combined Modality Therapy; Dacarbazine; Female; Glioblastoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Radiotherapy Dosage; Survival Analysis; Time Factors; Tomography, X-Ray Computed

2003
[Management of malignant gliomas diagnosed during pregnancy].
    Revue neurologique, 2006, Volume: 162, Issue:3

    Topics: Abortion, Therapeutic; Adrenal Cortex Hormones; Adult; Algorithms; Anesthesia, General; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbamazepine; Carmustine; Case Management; Cesarean Section; Chemotherapy, Adjuvant; Cranial Irradiation; Craniotomy; Dacarbazine; Female; Frontal Lobe; Glioblastoma; Humans; Infant, Newborn; Intracranial Hypertension; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Paresis; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Prenatal Exposure Delayed Effects; Radiotherapy, Adjuvant; Remission Induction; Supratentorial Neoplasms; Temozolomide; Temporal Lobe

2006
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas].
    Bulletin du cancer, 1999, Volume: 86, Issue:3

    Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds

1999
Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study on human glioblastoma cell lines.
    Anti-cancer drugs, 1999, Volume: 10, Issue:4

    Topics: Antineoplastic Agents; Brain Neoplasms; Cell Survival; Drug Interactions; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Glioblastoma; Humans; Lithium Compounds; Meglumine; Nitrosourea Compounds; Organophosphorus Compounds; Tumor Cells, Cultured

1999
Up-front chemotherapy with fotemustine (F) / cisplatin (CDDP) / etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas.
    European journal of cancer (Oxford, England : 1990), 2000, Volume: 36, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Etoposide; Female; France; Glioblastoma; Humans; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate; Treatment Outcome

2000